Camel whey protein enhances diabetic wound healing in a streptozotocin-induced diabetic mouse model: the critical role of β-Defensin-1, -2 and -3 by Gamal Badr
Badr Lipids in Health and Disease 2013, 12:46
http://www.lipidworld.com/content/12/1/46RESEARCH Open AccessCamel whey protein enhances diabetic wound
healing in a streptozotocin-induced diabetic
mouse model: the critical role of β-Defensin-1, -2
and -3
Gamal Badr1,2Abstract
Background: Delayed wound healing is considered one of the most serious diabetes-associated complications. The
presence of replicating organisms such as bacteria within a diabetic’s wound is considered one of the most
important factors that impair cutaneous wound healing and the potential cellular and/or molecular mechanisms
that are involved in the healing process. Defensins, which are anti-microbial peptides, have potent bactericidal
activity against a wide spectrum of the bacterial and fungal organisms that are commonly responsible for wound
infections. We recently demonstrated that camel whey proteins (WPs) expedite the healing of diabetic wounds by
enhancing the immune response of wounded tissue cells and by alleviating some of the diabetic complications.
Methods: In the present study, we investigated the effects of WP supplementation on the mRNA and protein
expression levels of β-defensin-1 (BD-1), 2 and 3 and subsequently on the wound healing process in a
streptozotocin (STZ)-induced diabetic mouse model. In this study, three groups of mice were used (10 mice per
group): group 1, the non-diabetic mice (control); group 2, the diabetic mice; and group 3, the diabetic mice that
received a daily supplement of undenatured WP (100 mg/kg of body weight) via oral gavage for 1 month.
Results: Compared with the non-diabetic control mice, the diabetic mice exhibited delayed wound closure that
was characterized by a reduction in hydroxyproline content (indicator of collagen deposition), a marked elevation
in free radical levels and a prolonged elevation in the levels of inflammatory cytokines, including interleukin-6 (IL-6),
transforming growth factor-beta (TGF-β) and tumor necrosis factor-alpha (TNF-α). Interestingly, compared with the
diabetic mice that did not receive WP supplementation, the diabetic mice with WP had an accelerated closure and
healing process of their wounds. The WP supplementation also decreased their levels of free radicals and restored
their hydroxyproline content; proinflammatory cytokine levels; and expression of BD-1, 2 and 3 in the wounded
tissue.
Conclusion: WP supplementation may be beneficial for improving the healing and closure of diabetic wounds.
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Impaired wound healing, a common complication of dia-
betes mellitus, is characterized by diminished collagen
production and impaired angiogenesis [1]. These compli-
cations are caused by the action of released free radicals
[2], which damage multiple cellular components, such as
lipids, proteins and DNA. Furthermore, multiple factors
in the diabetic wound, including increased apoptosis,
decreased vascular recovery, an aberrant inflammatory
response and delayed cellular turnover, contribute to
impaired wound healing [3]. Additionally, the production
of reactive oxygen species (ROS) by inflammatory cells
and other cell types in the wound is required for defense
against invading bacteria. Moreover, at physiological
levels, ROS are also important regulators of various intra-
cellular signaling pathways [4]. Oxidative stress is an
important pathogenic factor in diabetic wound complica-
tions and affects cell replication and life span. Intracellular
glutathione (GSH) can normalize skin cell functions that
are disrupted by in vitro cell growth under hyperglycemic
conditions [5]. Although ROS plays crucial roles in cell
signaling and in the immune response, higher levels of
ROS cause oxidative stress during wound healing. There-
fore, regulating oxidative stress and the inflammatory
response is an important factor in cutaneous wound
healing. Wound healing can be defined as a complex,
multi-stage process that involves distinct phases: inflam-
mation, the formation of granulation tissue, the produc-
tion of new structures and tissue remodeling [6].
Moreover, many factors can interfere with one or more
phases of this process and thus may affect wound healing
by causing improper or impaired tissue repair. Collagen is
the predominant extracellular protein in the granulation
tissue of a healing wound. In addition, the synthesis of
collagen rapidly increases in the wound area soon after an
injury, and this increase in collagen provides strength and
integrity to the tissue matrix. The measurement of
hydroxyproline, which is produced by the breakdown of
collagen, has been used as an index of collagen turnover
[7]. The cytokines and chemokines secreted by skin-
resident cells (keratinocytes, fibroblasts and endothelial
cells) and by inflammatory cells are involved in wound
healing. Proinflammatory cytokines, including interleukins
1α and 1β (IL-1α and IL-1β), IL-6 and tumor necrosis
factor alpha (TNF-α), play important roles in wound re-
pair, such as the stimulation of keratinocyte and fibroblast
proliferation, synthesis and breakdown of extracellular
matrix proteins, fibroblast chemotaxis and regulation of
the immune response [8]. In addition, recent reports have
indicated that the dysregulation of TNF-α impairs the
healing of diabetic wounds and that this dysregulation
may involve enhanced apoptosis and decreased prolifer-
ation of fibroblasts [9]. Previous studies have demon-
strated that transforming growth factor-β (TGF-β)plays critical roles in wound repair. This cytokine func-
tions in leukocyte chemotaxis, fibroblast and smooth
muscle cell mitogenesis and extracellular matrix depos-
ition during granulation tissue formation [8,10]. One
common denominator associated with the regulation of
wound healing events is human β-defensin 2 (BD-2).
Skin wounding induces cutaneous BD-2 expression,
and diabetic wounds have been associated with inad-
equate human β-defensin expression [11]. Human BD-2
may also participate in other aspects of innate immun-
ity because it chemoattracts monocytes and immature
dendritic cells [12]. In burned skin, human β-defensin 1
(BD-1) is expressed by the dermal glands, including
hair shafts. Moreover, human BD-2 and 3 have been
found in the remaining keratin layers and glands of the
lower dermis [13]. In a recently published study, burn
wounds exhibited a moderately lower expression of
BD-1 than healthy tissues [14].
The improvement in immune function using dietary
antioxidants can play an important role in the preven-
tion of many human diseases and diabetic complications.
Camel whey proteins (WPs) include a heterogeneous
group of proteins, including serum albumin, α-lactalbumin,
immunoglobulin, lactophorin and peptidoglycan recog-
nition protein [15]. Dietary whey supplementations may
improve wound healing by increasing GSH synthesis
and cellular antioxidant defense [16]. Therefore, WPs
may be a therapeutic tool for the treatment of oxidative
stress-associated diseases [17]. The oral administration
of an undenatured WP increases the GSH levels of
severa GSH-deficient patients, including those with
advanced human immunodeficiency virus (HIV) infec-
tion [18]. Recent studies have indicated that whey
increases the antioxidant activity in the body, combats
fatigue and inflammation, hastens healing, improves
stamina and may discourage related infections due to
the immune system-enhancing and natural antibiotic
properties of its components [19,20]. Nevertheless, few
studies have investigated the influence of WPs on wound
healing. The aim of this study was to investigate the effects
of WP supplementation on the mRNA and protein ex-
pression levels of BD-1, 2 and 3 and subsequently to
observe the effects of WP on the wound healing process
in a streptozotocin (STZ)-induced diabetic mouse model.
Materials and methods
Preparation of WPs
Raw camel milk was collected from healthy female
camels from Assiut Governorate, Egypt. The milk was
then centrifuged to remove the cream. The skim milk
obtained was acidified to pH 4.3 using 1 N HCl at room
temperature and centrifuged at 10,000 × g for 10 min
to precipitate the casein. The resultant whey, which
contained the WPs, was saturated with ammonium sulfate
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precipitated WPs were dialyzed against 20 volumes of dis-
tilled water for 48 h using a molecular-porous membrane
with a molecular weight cut off (MWCO) of 6,000–8,000
kDa. The dialysate containing the undenatured WPs was
freeze-dried and refrigerated until use.Chemicals
STZ was obtained from Sigma Chemicals Co. (St. Louis,
MO, USA). STZ was dissolved in cold 0.01 M citrate buffer
(pH 4.50) and was always freshly prepared for immediate
use (within 5 min).Animals and experimental design
A total of 30 sexually mature 12-week-old male Swiss
Webster (SW) mice, each of which weighed between 25
and 30 g, were obtained from the Central Animal House
of the Faculty of Pharmacy at King Saud University. All
of the animal procedures were conducted in accordance
with the standards set forth in the Guidelines for the
Care and Use of Experimental Animals by the Committee
for the Purpose of Control and Supervision of Experi-
ments on Animals (CPCSEA) and the National Institutes
of Health (NIH). The study protocol was approved by the
Animal Ethics Committee of King Saud University in ac-
cordance with the principles of Declaration of Helsinki.
All of the animals were allowed to acclimate to the metal
cages inside a well-ventilated room for 2 weeks prior
to experimentation. The animals were maintained
under standard laboratory conditions (23°C, 60–70%
relative humidity and a 12-h light/dark cycle), fed a
diet of standard commercial pellets and given water ad
libitum. All of the mice were fasted for 20 h before dia-
betes induction. The mice (n = 20) were rendered dia-
betic with an intraperitoneal (i.p.) injection of a single
dose of STZ (60 mg/kg of body weight) in 0.01 M
citrate buffer (pH 4.5) [21]. The mice in the control
group (n = 10) were injected with the vehicle (0.01 M
citrate buffer, pH 4.5). The animals were divided into
three experimental groups: group 1 was the control
non-diabetic mice that received a daily supplement of
250 μl of distilled water through oral gavage for one
month; group 2 was the diabetic mice that received
250 μl of distilled water daily through oral gavage for
one month; and group 3 was the diabetic mice that
were daily supplemented with undenatured WP (100
mg/kg of body weight) dissolved in 250 μl of distilled
water via oral gavage for one month. Therefore, the
volume of the daily supplement received by each
mouse in the three groups was constant and did not
exceed 250 μl. The optimal dose of WP was deter-
mined in our laboratory based on the LD50 and several
established measured parameters.Excisional wound preparation and macroscopic
examination
Following the diabetes induction in groups 2 and 3, the
mice in each group were wounded at the age of 12 weeks.
The wounding of the mice was performed as described
previously [22]. Briefly, the mice were anaesthetized with
a single i.p. injection of ketamine (80 mg/kg of body
weight) and xylazine (10 mg/kg of body weight). The hair
on the back of each mouse was cut, and the back was sub-
sequently wiped with 70% ethanol. Six full-thickness
wounds (5 mm in diameter, 3–4 mm apart) were made on
the back of each mouse by excising the skin and the
underlying panniculus carnosus. The wounds were
allowed to form a scab. Skin biopsy specimens were
obtained from the animals 1, 4, 7, 10 and 13 days post
wound injury. At each time point, an area that included
the scab, the complete epithelial and dermal compart-
ments of the wound margins, the granulation tissue and
parts of the adjacent muscle and subcutaneous fat tissue
was excised from each individual wound. As a control, a
similar amount of skin was collected from the backs of
non-wounded normal mice. Each wound site was digitally
photographed at the indicated time points to determine
the wound area. Changes in the wound areas were
expressed as the percentage of the initial wound areas. At
the indicated time points, tissue from two wounds from
each of 10 animals (for a total of 20 wounds) was collected
for RNA analysis.
Histopathological studies
A specimen sample was isolated from each group of mice
on day 13 after wounding for histopathological examin-
ation. The skin specimens were immediately fixed in 10%
(v/v) neutral buffered formalin, and the fixative solution
was replaced every 2 days until the tissues hardened. Each
specimen was embedded in a paraffin block, and thin sec-
tions (3 μm) were prepared and stained with hematoxylin
and eosin (H&E) for general morphological observations.
Blood analysis
The blood glucose levels were determined using an
AccuTrend sensor (Roche Biochemicals, Mannheim,
Germany). The serum insulin level was analyzed by
Luminex (Biotrend, Düsseldorf, Germany) according to
the manufacturer’s instructions.
Quantification of biochemical parameters in wound tissue
Measurement of the hydroxyproline content
After drying for 24 h at 120°C, the amount of hydroxy-
proline, which is a major constituent of collagen in skin
wound sites, was measured to index the collagen accu-
mulation at the wound site, as previously described [23].
The hydroxyproline contents were expressed as the
amount (mg) per wound.
Badr Lipids in Health and Disease 2013, 12:46 Page 4 of 11
http://www.lipidworld.com/content/12/1/46Measurement of the cytokine levels
A 2.0-mm punch biopsy at the wound site was harvested
and frozen in liquid nitrogen. The specimens were ho-
mogenized in cytoplasmic lysis buffer containing protease
inhibitors (Roche Diagnostics), disrupted using Fast Prep
(Q-Biogene, Solon, OH, USA) and centrifuged at 5000 × g
for 10 min. The protein concentration in each lysate was
determined using the bicinchoninic acid (BCA) protein
assay kit (Pierce). The levels of IL-6, TGF-β and TNF-α in
the supernatants were determined using a commercial
ELISA kit (R&D Systems, France) according to the manu-
facturer’s instructions. For each sample, the data were
expressed as the amount of the target molecule (pico-
grams) divided by the amount of total protein (milligrams).
Measurement of the free radical levels
The tissue lysates were also used to determine the ROS levels
using 2,7-dichlorodihydrofluorescein diacetate (H2DCF-DA;
Beyotime Institute of Biotechnology, Haimen, China).
The hydroperoxide levels were evaluated using a free
radical analytical system (FRAS 2, Iram, Parma, Italy),
which is a colorimetric test that takes advantage of the
ability of hydroperoxide to generate free radicals after
reacting with transitional metals.
Extraction of total RNA and RT-PCR analysis
Total RNA was isolated from the wounded skin samples
using the TRIzol (Invitrogen Life Technologies, France)
reagent according to the manufacturer’s instructions. Be-
fore reverse transcription, the RNA was treated with
RNase-free DNase I following the manufacturer’s proto-
col. Three micrograms of the total RNA was used for
the synthesis of cDNA using a Superscript III RT kit
(Invitrogen Life Technologies, France). Unique primer
sets for mouse BD-1, 2 and 3 and β-actin were designed
(Table 1) based on sequences deposited in the National
Center for Biotechnology Information and were synthe-
sized by Invitrogen Life Technologies. The PCR was
performed using 1 μl of cDNA in a reaction mix with
Taq polymerase (Invitrogen Life Technologies). The PCR














(F), Forward primer; (R), reverse primer.the PCR conditions were optimized to allow a semi-
quantitative comparison of the results. The digital
images of the bands separated on ethidium bromide-
stained agarose gels were quantified using the NIH
Image Analysis Software. The intensity of each primer
product was normalized to the intensity of the β-actin
primer product and expressed relative to the levels
found in the injured skin of the control non-diabetic
mice.
Western blot analysis
The skin and wound tissue biopsies were homogenized in
lysis buffer (1% Triton X-100, 137 mM NaCl, 10% gly-
cerol, 1 mM dithiothreitol, 10 mM NaF, 2 mM Na3VaO4,
5 mM ethylenediaminetetraacetic acid, 1 mM phenyl-
methylsulfonylfluoride, 5 ng/ml aprotinin, 5 ng/ml leupeptin
and 20 mM Tris/HCl, pH 8.0), and the lysates were prepared
as previously described [24]. Fifty micrograms of total protein
from the skin lysates was analyzed using SDS polyacrylamide
gel electrophoresis (SDS-PAGE) and western blot analysis.
The proteins were transferred to a nitrocellulose membrane
(0.2 μm, Amersham Hybond ECL, GE Healthcare, Freiburg,
Germany), blocked for 1 h in blocking buffer (5% (wt/vol)
BSA in PBS + 0.05% Tween), incubated overnight at
4°C in 3% (wt/vol) BSA in PBS + 0.05% Tween
containing either 1:250 anti-mBD-1, 1:250 anti-mBD-3
and 1:1000 mBD-3 antibodies (all from Santa Cruz Bio-
technology, Santa Cruz, CA, USA) or 1:1000 anti-β
actin antibody (Sigma). The membrane was washed five
times with PBS + 0.05% Tween for 5 minutes and incu-
bated for 1 h in 3% (wt/vol) BSA in PBS + 0.05% Tween
containing a 1:5000 dilution of goat anti-rabbit or rabbit
anti-goat IgG conjugated to horseradish peroxidase (HRP,
Dianova, Hamburg, Germany). After five additional
washes, the proteins were visualized using an enhanced
chemiluminescence (ECL, SuperSignal West Pico chemi-
luminescent substrate; Perbio, Bezons, France) detection
system. The ECL signal was detected on Hyperfilm ECL.
To quantify the band intensities, the films were scanned,
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The data were first tested for normality (using the
Anderson-Darling test) and for variance homogeneity
prior to any further statistical analyses. The data were
normally distributed and were expressed as the mean ±
SEM (standard error of the mean). The differences be-
tween the groups were analyzed by one-way analysis of
variance (for more than two groups) followed by Tukey’s
post-test using the SPSS software (version 17). The data
are expressed as the mean ± SEM. The differences were
considered statistically significant at *P< 0.05 for diabeticFigure 1 Macroscopic changes in the skin excisional wound
sites that determine wound closure. (A) The changes in the
percentage of wound closure at each time point after wound injury
were measured relative to the original wound area on day 1. The
accumulated data on the changes in wound closure from ten
individual mice in each group are shown. The data are presented as
the mean ± SEM. *P < 0.05, diabetic vs. control; +P < 0.05, diabetic +
WP vs. control; #P < 0.05, diabetic + WP vs. diabetic. (B) The
hydroxyproline content, which was used as an index of the collagen
accumulation at the wound site, was determined. The data are
presented as the mean ± SEM. *P < 0.05, diabetic vs. control; +P < 0.05,
diabetic + WP vs. control; #P < 0.05, diabetic + WP vs. diabetic.vs. control; +P< 0.05 for diabetic + WP vs. control;
or #P< 0.05 for diabetic + WP vs. diabetic.
Results
Supplementation with camel WP improved wound
closure in diabetic mice
We first evaluated the macroscopic changes in the skin ex-
cisional wound sites of the control mice, diabetic mice andFigure 2 Histological examination of healed wound sections
stained with H&E. The photomicrographs show the healed wound
sections isolated from mice in the (A) control, (B) diabetic and
(C) diabetic +WP group on day 13 after wounding. The
photomicrographs were obtained at a magnification of ×200.
Abbreviations: bc, blood capillaries; C, collagen fibers; f, fibroblast.
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were obtained immediately after the injury. We observed
that the wound sites of the mice in all of the experimental
groups exhibited similar morphology on day 1 post injury,
whereas the wounds of the control and WP-supplemented
diabetic groups were almost similarly closed by day 13 post
injury. By contrast, the diabetic mice exhibited delayed
wound closure. Data from 10 individual mice in each
group were used to determine the changes in the percent-
age of wound closure at each time point compared with
the original wound area (Figure 1A). The diabetic mice
supplemented with camel WP had accelerated wound clos-
ure and thus the eventual healing compared with the dia-
betic mice, which exhibited delayed wound closure.
Because hydroxyproline is a major constituent found
almost exclusively in collagen, we used its content as an
indicator of the amount of collagen type I at the wound
sites. The accumulated data from 10 individual mice in
each group demonstrated that compared with the
control mice, the diabetic mice had significantly lower
hydroxyproline content and decreased wound closure
(Figure 1B). Compared with the control mice, the
diabetic mice exhibited less collagen accumulation at the
wound sites, which confirmed the presence of a delayed
healing process. However, compared with the diabetic
mice, the diabetic mice supplemented with camel WP
exhibited a significant restoration of their hydroxyprolineTable 2 Effect of WP supplementation on the levels of free ra
Blood paramete





















Diabetic + WP 261±25.5 +
The levels of blood glucose and insulin in the three groups of mice were monitored
hydroperoxide in the excisional wound tissue collected from the three groups of m
accumulated data from 10 individual mice from each group are shown. The data w
statistical analysis. The data were normally distributed and are expressed as the me
#P < 0.05, diabetic + WP vs. diabetic (ANOVA with Tukey’s post-test).content. These results suggest that collagen production
was enhanced through the oral administration of WP.
Effect of WP supplementation on the histopathological
features of the healed wounds of diabetic mice
The histopathological characteristics of the healed
wounds on day 13 after wounding are shown in Figure 1.
The control group exhibited good wound healing with
complete re-epithelialization and well-formed connective
tissue (Figure 2A). Conversely, the tissue obtained from
the diabetic group exhibited disorganized fibroblasts, an
absence of collagen fiber deposition and the infiltration
of inflammatory cells (arrows) (Figure 2B). Interestingly,
a greater degree of tissue regeneration was observed in
the diabetic + WP group, as demonstrated by complete
epithelization, significantly higher collagen deposition
and the presence of granulation tissues (Figure 2C).
WP treatment of diabetic mice decreased the levels of
free radicals in wounded tissue
To optimize all of the parameters and conditions of the
animal models during the experiments, the blood glu-
cose and insulin levels of the mice in the three groups
were monitored throughout the indicated time points
post wound injury (Table 2). We observed that the blood
glucose levels of the WP-treated diabetic mice were sig-
nificantly lower than those of the diabetic mice and weredicals in the wound tissues of diabetic mice




1.7±0.15 *# 92±8.4 *# 59.1±4.6 *#
3.1±0.29 + 68±7.1 + 33.4±4.2 +
6.4±0.61 58±6.2 17±2.1
1.4±0.3 *# 117±12 *# 67±5.3 *#
2.9±0.25 + 79±8.1 + 37.6±4.1 +
5.7±0.5 49.8±5.1 27.1±2.9
1.1±0.22 *# 132±14 *# 59.8±5.5 *#
3.4±0.3 + 71.7±8 + 42.1±4.1 +
7.1±0.75 61.5±5.6 19.9±1.7
1.6±0.19 *# 126±13 *# 48.6±4.9 *#
3.9±0.38 + 83±7.5 + 34±3.8 +
6.4±0.6 52.3±4.8 15.5±1.1
1.45±0.2 *# 89.9±7.8 *# 39.8±3.2 *#
3.3±0.3 + 67.1±7.2 + 24.6±2.6 +
on days 1, 4, 7, 10 and 13 post wounding. The levels of ROS and
ice on days 1, 4, 7, 10 and 13 post wounding were also measured. The
ere first tested for normality and variance homogeneity prior to any further
an ± SEM. *P < 0.05, diabetic vs. control; +P < 0.05, diabetic + WP vs. control;
Figure 3 Effect of WP supplementation on pro-inflammatory
cytokines in the wound tissue of diabetic mice. The levels of IL-6
(A), TGF-β (B) and TNF-α (C) in the excisional wound tissue collected
from the three groups of mice on days 1, 4, 7, 10 and 13 post
wounding were measured using ELISAs. The cytokines levels from the
control skin (day 0, an hour before wounding) were also measured in
the three groups of mice. The data were first tested for normality and
variance homogeneity prior to any further statistical analysis. The data
were normally distributed, are presented as the amount of cytokines
(pg) per mg of tissue and are expressed as the mean ± SEM. *P < 0.05,
diabetic vs. control; +P < 0.05, diabetic + WP vs. control; #P < 0.05,
diabetic + WP vs. diabetic (ANOVA with Tukey’s post-test).
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WP-treated diabetic mice had significantly higher levels
of insulin than the non-treated diabetic mice throughout
the wound healing period. The control and WP-treated
diabetic mice had significantly lower hydroperoxide and
ROS levels in the wound tissue than the diabetic mice
(Table 2).
The impact of WP supplementation on the levels of
proinflammatory cytokines in diabetic mice
We monitored the levels of the proinflammatory cyto-
kines (IL-6, TGF-β and TNF-α) that control the process
of wound healing in the wounded tissue of the three
groups of mice. The accumulated data from 10 individ-
ual mice from each group are shown (Figure 3). The
diabetic mice had aberrant and significantly higher levels
of IL-6 (Figure 3A), TGF-β (Figure 3B) and TNF-α
(Figure 3C) 1 through 13 days post injury than the con-
trol and WP-treated diabetic mice, suggesting that the
wound healing in diabetic mice includes a prolonged
proinflammatory phase. By contrast, the supplementa-
tion of diabetic mice with WP significantly restored the
levels of IL-6, TGF-β and TNF-α.
Supplementation with WP during diabetes enhanced the
expression of β-defensin-1, -2 and -3 in wounded tissue
RT-PCR was performed to measure the mRNA expres-
sion levels of BD-1, 2 and 3, which play important roles
in the wound healing process, in the excisional wound
tissues that were collected from the mice on days 1, 4, 7,
10 and 13 post injuries. The BD-1 (Figure 4A), 2
(Figure 4B) and 3 (Figure 4C) levels from one represen-
tative experiment are shown. The accumulated data on
the expression levels of BD-1 (Figure 4D), 2 (Figure 4E)
and 3 (Figure 4F), which were normalized to the expres-
sion of β-actin, from three individual mice from each
group are shown. The diabetic mice had significantly
lower expression levels of BD-1, 2 and 3 throughout the
indicated wound healing time intervals than the control
and WP-supplemented diabetic mice. Interestingly, the
WP supplementation in the diabetic mice restored the
expression levels of BD-1, 2 and 3.
WP supplementation upregulated the protein levels of
BD-1, 2 and 3 in the wounded tissues of diabetic mice
To confirm the expression of β-defensins after WP sup-
plementation, western blot analysis measured the protein
expression levels of BD-1, 2 and 3 in the excisional wound
tissues collected from the 3 groups of mice on days 1, 4, 7,
10 and 13 post injury. The protein expression levels of
BD-1 (Figure 5A), 2 (Figure 5B) and 3 (Figure 5C) from
one representative experiment are shown. The diabetic
mice had longer wound healing times, which were corre-
lated with the aberrant protein expression levels of BD-1,2 and 3 throughout the measured time intervals of the
healing period, than the control and WP-supplemented
diabetic mice. The accumulated data on the expression
levels of BD-1 (Figure 5D), 2 (Figure 5E) and 3 (Figure 5F),
which were normalized to the expression levels of β-actin,
from three individual mice from each group are shown.
The diabetic mice exhibited significantly lower expression
levels of BD-1, 2 and 3 throughout the indicated wound
Figure 4 Effect of WP supplementation on the mRNA expression levels of murine BD-1, 2 and 3 in the wounded tissues. The mRNA
levels of mBD-1, 2 and 3 in the three groups of mice at the indicated time points post wounding were measured using RT-PCR. The expression
levels of mBD-1 (A), 2 (B) and 3 (C) on the indicated number of days post wounding from one representative experiment are shown. The
accumulated data on the expression of mBD-1 (D), 2 (E) and 3 (F) from three individual mice from each group are shown, and the results are
expressed as the mean ± SEM. *P < 0.05, diabetic vs. control; +P < 0.05, diabetic + WP vs. control; #P < 0.05, diabetic + WP vs. diabetic.
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supplemented diabetic mice. Interestingly, the WP supple-
mentation of diabetic mice significantly restored the
expression levels of BD-1, 2 and 3.
Discussion
Although the role of nutrition is well established in
immune and inflammatory diseases, its role in normal
physiological processes, such as cutaneous wound healing,
is not well understood [25]. Therefore, several studies have
attempted to understand the underlying defects in the
wound healing of diabetic patients. We hypothesized that
a dietary antioxidant, such as WP supplementation, mayimprove the delayed wound healing in diabetic patients
through the modulation of blood glucose levels, oxidative
stress, growth factors and the inflammatory response. The
significant reduction in the wound size that was observed
after WP treatment was correlated with various histo-
pathological findings: increased epithelization activity,
angiogenesis, granulation tissue formation and extracellu-
lar matrix remodeling. Collagen not only confers strength
and integrity to the tissue matrix but also plays an import-
ant role in the homeostasis and epithelialization in the
later stages of wound healing [26]. In this study, we found
that the macroscopic changes and the rate of wound clos-
ure were significantly lower in the WP-supplemented
Figure 5 Effect of WP supplementation on the protein expression levels of murine BD-1, 2 and 3 in the wounded tissues. The protein
levels of mBD-1, 2 and 3 in the 3 groups of mice at the indicated time points post wounding were measured using western blot. The expression
levels of mBD-1 (A), 2 (B) and 3 (C) on the indicated days post wounding from one representative experiment are shown. The accumulated data
on the expression of mBD-1 (D), 2 (E) and 3 (F) from three individual mice from each group are shown, and the results are expressed as the
mean ± SEM. *P < 0.05, diabetic vs. control; +P < 0.05, diabetic + WP vs. control; #P < 0.05, diabetic + WP vs. diabetic.
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mice. The accelerated wound closure of the WP-treated
diabetic mice may be attributed to increases in GSH syn-
thesis and the cellular antioxidant defense [16]. Because
hydroxyproline is a major constituent that is found almost
exclusively in collagen, we used its content as an indicator
of the amount of collagen type I at the wound sites. We
observed that the defective wound repair in the diabetic
mice was associated with lower hydroxyproline content;
however, the hydroxyproline content increased after the
WP treatment. Similarly, Zhang et al. [27] observed that
the impaired wound healing in diabetic rats is associated
with lower hydroxyproline content. A previous studyindicated that the impaired collagen deposition in the
acute wounds of type 1 diabetes patients is potentially due
to decreased fibroblast proliferation [28]. The enhanced
level of hydroxyproline and thus the increased level of
collagen likely strengthened the regenerated tissue in the
diabetic mice supplemented with WP. Our data revealed
that the delayed wound repair observed in the diabetic
mice was associated with a significant increase in the
blood glucose levels and an obvious decrease in the insulin
levels; these effects were reversed by WP supplementation.
In previous studies, dietary antioxidant supplementation
itself did not affect blood glucose levels [29]. However, the
dietary antioxidant supplementation used in this study
Badr Lipids in Health and Disease 2013, 12:46 Page 10 of 11
http://www.lipidworld.com/content/12/1/46significantly lowered the blood glucose levels of the dia-
betic mice even though the blood glucose levels of these
diabetic mice were higher than normal levels. In addition,
other studies have shown that the addition of whey to
meals stimulates insulin release. Moreover, the addition of
whey to a lunch meal consisting of mashed potatoes and
meatballs reduces the postprandial blood glucose excur-
sion in patients with type 2 diabetes [30]. Oxidative stress
is increased by enhancing the rate of ROS production and
decreasing the antioxidant defense in diabetic subjects. In
this study, we observed that the treatment of diabetic mice
with WP lowered the levels of hydroperoxide and free
radicals in wounded tissue. Importantly, we observed that
the WP treatment improved wound healing in the diabetic
mice because the treatment restored the elevated levels of
proinflammatory cytokines (IL-6, TGF-β and TNF-α) in the
wounded tissues, which limit the prolonged inflammation.
This finding demonstrates the mechanism underlying the
enhanced immune response and improved wound healing
observed in diabetic mice supplemented with WP. These
results are corroborated by a previous study that indicated
that lactoferrin can regulate the levels of TNF-α and IL-6,
which decrease inflammation and mortality [31]. Further-
more, our previous study confirmed these finding [32].
Skin wounding affects the expression of defensins,
especially human BD-2 and 3. These skin-derived
defensins can effectively promote wound healing due to
their antimicrobial effects on pathogens and their stimu-
latory effects on wound repair cells and immune cells
[12,33]. The present study showed correlations between
wound closure and the expression of β-defensin after
WP supplementation; these correlations show that the
supplementation of diabetic mice with WP significantly
restored the mRNA and protein expression levels of BD-
1, 2 and 3. We therefore hypothesize that it is possible
to accelerate the wound closure rate by regulating the
β-defensin levels through WP supplementation. This
effect can be attributed to lower oxidative stress, as was
confirmed by the decreased ROS and hydroperoxide levels
detected during the wound healing period. Similar obser-
vations suggest that defensins play a role in cell division,
immune cell attraction and maturation, cell differentiation
and the reorganization of epithelial tissues during the
wound healing phases [33]. In conclusion, the results of
this study suggest that WP supplementation induces syn-
ergetic effects that improve the conditions of diabetes
through the regulation of insulin and blood glucose levels,
the decrease of oxidative stress and the restoration of the
levels of proinflammatory cytokines and β-defensin that
accelerate cutaneous wound healing.
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